Today I interview Michael Fero the Founder and President of TeselaGen. Michael and the team at TeselaGen have created an AI enabled operating system that can help biopharma companies design their next drug. TeselaGen uses methods from machine learning and synthetic biology to help Pharmaceutical companies build and optimize cancer fighting drugs and vaccines by letting experimental data drive the discovery process.
Subscribe to Life Science Success for cutting-edge insights, expert interviews, and a vibrant community. Your subscription fuels our mission and keeps you at the forefront of life sciences.
